Review highlights next-generation cancer therapies targeting PIK3CA mutations

Post author:admin
Post published:February 25, 2025
Post category:uncategorized

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging targeted therapies designed to improve treatment efficacy while reducing side effects.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Time-restricted eating combined with exercise may boost fat loss

From crude lysate to purity with high-precision AAV capsid measurement with Bio-Rad’s new ddPCR Kit

Scientists discover how hospital superbug rapidly evolves resistance to frontline treatment

Helpful Links

Subscribe To Us